NCT03501745

Brief Summary

Through remote management and propaganda of intelligent mobile phone, the standard rate of blood pressure control and the change of renal function were observed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 18, 2018

Completed
13 days until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

April 18, 2018

Status Verified

March 1, 2018

Enrollment Period

6 months

First QC Date

March 30, 2018

Last Update Submit

April 17, 2018

Conditions

CKD

Outcome Measures

Primary Outcomes (2)

  • Control rate of blood pressure control

    Average blood pressure of each patient ,thenStatistics of the number of blood pressure control standards .

    1 year

  • Drug compliance

    Take medications according to the doctor's advice

    1 year

Study Arms (2)

Management Group

OTHER
Behavioral: WeChat

control group

OTHER
Behavioral: WeChat

Interventions

WeChatBEHAVIORAL

Through remote management and propaganda of intelligent mobile phone, the standard rate of blood pressure control and the change of renal function were observed.

Management Groupcontrol group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis in line with the 2012 international kidney disease: improving global outcomes (kidney disease improving global out-comes, KDIGO) of chronic kidney disease diagnosis standard of hypertension diagnosis, "China Hypertension Prevention Guide 2010" diagnostic criteria;
  • and will have the use of intelligent mobile phone, and a network connection;
  • at the age of 18-70.

You may not qualify if:

  • GFR\<15 ml/min or start replacement therapy;
  • do not understand Chinese, do not understand Chinese;
  • malignant tumor patients;
  • have mental illness;
  • there is consciousness disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pengli Luo

Qinghai, Xining, China

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy chief physician

Study Record Dates

First Submitted

March 30, 2018

First Posted

April 18, 2018

Study Start

May 1, 2018

Primary Completion

November 1, 2018

Study Completion

May 1, 2019

Last Updated

April 18, 2018

Record last verified: 2018-03

Locations

CN(1)